C181790Level 4
Gemcitabine/Margetuximab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of gemcitabine and margetuximab that can be used for the treatment of recurrent and metastatic HER-2 (EGFR2; ErbB2)-positive breast cancer.
**Synonyms:** - Gemcitabine and Margetuximab - Gemcitabine-Margetuximab - Gemcitabine-Margetuximab Regimen - Gemcitabine/Margetuximab - Gemcitabine/Margetuximab-cmkb Regimen - Margenza/Gemzar - Margetuximab Plus Gemcitabine - Margetuximab-Gemcitabine - Margetuximab/Gemcitabine - Margetuximab/Gemcitabine Regimen
GET
/api/v1/systems/nci_thesaurus/nodes/C181790Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.